Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
16 February 2023 - 10:06PM
Edgar (US Regulatory)
00017023182022-04-012022-09-300001702318us-gaap:PrivatePlacementMember2022-09-300001702318ahg:AmericanDepositoryMember2022-04-012022-09-300001702318ahg:AmericanDepositoryMember2018-12-102018-12-100001702318ahg:AmericanDepositoryMember2018-12-100001702318us-gaap:AdditionalPaidInCapitalMember2021-04-012021-09-300001702318us-gaap:CommonStockMember2021-04-012021-09-300001702318us-gaap:RetainedEarningsMember2022-09-300001702318us-gaap:NoncontrollingInterestMember2022-09-300001702318us-gaap:AdditionalPaidInCapitalMember2022-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001702318us-gaap:RetainedEarningsMember2022-03-310001702318us-gaap:NoncontrollingInterestMember2022-03-310001702318us-gaap:AdditionalPaidInCapitalMember2022-03-310001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001702318us-gaap:RetainedEarningsMember2021-09-300001702318us-gaap:AdditionalPaidInCapitalMember2021-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001702318us-gaap:RetainedEarningsMember2021-03-310001702318us-gaap:AdditionalPaidInCapitalMember2021-03-310001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-3100017023182018-07-232018-07-2300017023182018-07-222018-07-220001702318ahg:EquityIncentivePlan2016Member2018-03-312018-03-310001702318ahg:EquityIncentivePlan2016Member2016-04-012016-04-010001702318us-gaap:RestrictedStockUnitsRSUMember2022-09-3000017023182020-03-3100017023182019-03-3100017023182018-03-3100017023182018-04-012019-03-310001702318ahg:RevenueFromMedicalDevicesMember2022-04-012022-09-300001702318ahg:OnlineMarketplaceServicesAndOtherMember2022-04-012022-09-300001702318ahg:InterestMember2022-04-012022-09-300001702318ahg:RecommendationServiceRevenuesMember2021-04-012022-03-310001702318ahg:OnlineMarketplaceServicesAndOtherMember2021-04-012021-09-300001702318ahg:InterestMember2021-04-012021-09-300001702318ahg:RecommendationServiceRevenuesMember2020-04-012021-03-310001702318ahg:RecommendationServiceRevenuesMember2019-04-012020-03-310001702318srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Member2020-03-310001702318ahg:SosInformationTechnologyNewYorkIncMember2022-07-282022-07-280001702318srt:BoardOfDirectorsChairmanMember2021-07-012021-07-310001702318srt:BoardOfDirectorsChairmanMember2021-08-262021-08-260001702318srt:MinimumMemberus-gaap:OfficeEquipmentMember2022-04-012022-09-300001702318srt:MaximumMemberus-gaap:OfficeEquipmentMember2022-04-012022-09-300001702318us-gaap:OfficeEquipmentMember2022-09-300001702318us-gaap:OfficeEquipmentMember2022-03-310001702318us-gaap:RetainedEarningsMember2022-04-012022-09-300001702318us-gaap:RetainedEarningsMember2021-04-012021-09-300001702318us-gaap:PrivatePlacementMember2021-09-172021-09-1700017023182019-11-012019-11-300001702318us-gaap:NoncontrollingInterestMember2022-04-012022-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-09-3000017023182021-10-152021-10-150001702318srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Member2019-04-010001702318us-gaap:NonUsMember2022-04-012022-09-300001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-04-012022-09-300001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-04-012021-09-300001702318ahg:WeHealthyLimitedMember2022-09-300001702318ahg:WeHealthLimitedMember2022-09-300001702318ahg:TianjinHaohongyuanTechnologyCo.LtdMember2022-09-300001702318ahg:QindaoAksoHealthManagementCo.LimitedMember2022-09-300001702318ahg:HxChinaInvestmentLimitedMember2022-09-300001702318ahg:HxAsiaInvestmentLimitedMember2022-09-300001702318ahg:HexinInvestmentPrivateLimitedMember2022-09-300001702318ahg:HexindaiHongKongLimitedMember2022-09-300001702318ahg:BeijingHexinYonghengTechnologyDevelopmentCo.LtdMember2022-09-300001702318ahg:AksoRemoteMedicalConsultationCenterIncMember2022-09-300001702318ahg:AksoOnlineMeditechCo.Ltd.Member2022-09-300001702318ahg:AksoFirstHealthTreatmentCenterIncMember2022-09-300001702318ahg:WeHealthyLimitedMemberahg:OtherInvestorsMember2022-09-300001702318ahg:WeHealthyLimitedMember2022-09-300001702318ahg:WeHealthyLimitedMember2022-03-3100017023182019-04-012019-04-010001702318ahg:IndividualsMember2022-04-012022-09-300001702318ahg:SosInformationTechnologyNewYorkIncMember2022-04-012022-09-300001702318ahg:WeHealthLimitedMembercountry:US2022-04-012022-09-300001702318ahg:AksoRemoteMedicalConsultationCenterIncMembercountry:US2022-04-012022-09-300001702318ahg:AksoOnlineMeditechCo.Ltd.Membercountry:US2022-04-012022-09-300001702318country:US2022-04-012022-09-300001702318country:CN2022-04-012022-09-300001702318us-gaap:CommercialLoanMemberahg:WebaoLtdMember2021-08-260001702318us-gaap:CommercialLoanMemberahg:WebaoLtdMember2021-03-310001702318srt:BoardOfDirectorsChairmanMember2021-03-310001702318us-gaap:DiscontinuedOperationsHeldforsaleMemberahg:HexinECommerceCompanyLimitedMember2020-12-160001702318ahg:OnlineMarketPlaceSegmentMember2022-04-012022-09-300001702318ahg:SosInformationTechnologyNewYorkIncMember2022-01-240001702318ahg:SosInformationTechnologyNewYorkIncMember2022-01-242022-01-240001702318us-gaap:CommercialLoanMemberahg:WebaoLtdMember2021-08-262021-08-260001702318ahg:HealthDevicesSegmentMember2022-04-012022-09-300001702318ahg:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerThreeMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerOneMemberus-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:TreasuryStockMember2022-09-300001702318us-gaap:CommonStockMember2022-09-300001702318us-gaap:TreasuryStockMember2022-03-310001702318us-gaap:CommonStockMember2022-03-310001702318us-gaap:TreasuryStockMember2021-09-300001702318us-gaap:CommonStockMember2021-09-300001702318us-gaap:TreasuryStockMember2021-03-310001702318us-gaap:CommonStockMember2021-03-310001702318ahg:EquityIncentivePlan2016Memberdei:AdrMember2018-07-232018-07-230001702318ahg:EquityIncentivePlan2016Member2018-07-232018-07-230001702318us-gaap:PrivatePlacementMember2021-08-090001702318currency:CNY2022-09-300001702318currency:CNY2022-03-310001702318ahg:OnlineMarketPlaceSegmentMember2022-09-300001702318ahg:HealthDevicesSegmentMember2022-09-300001702318ahg:OnlineMarketPlaceSegmentMember2021-03-310001702318ahg:HealthDevicesSegmentMember2021-03-3100017023182021-03-3100017023182020-08-2400017023182020-08-230001702318us-gaap:PrivatePlacementMember2022-04-012022-09-3000017023182020-08-242020-08-240001702318ahg:EquityIncentivePlan2016Member2022-09-300001702318ahg:EquityIncentivePlan2016Member2022-03-310001702318ahg:EquityIncentivePlan2016Member2018-03-3100017023182020-04-012021-03-3100017023182019-04-012020-03-310001702318ahg:EquityIncentivePlan2016Member2022-04-012022-09-300001702318ahg:EquityIncentivePlan2016Member2021-04-012022-03-310001702318ahg:EquityIncentivePlan2016Member2019-04-012020-03-310001702318ahg:EquityIncentivePlan2016Member2020-03-310001702318ahg:LeaseAgreementWithRelatedPartiesMembersrt:BoardOfDirectorsChairmanMember2020-10-152020-10-1500017023182022-05-222022-05-220001702318ahg:HighTechnologyEnterprisesMemberahg:HexinEDigitalCo.ltdMembercountry:CN2022-04-012022-09-3000017023182020-05-012020-05-310001702318us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:DiscontinuedOperationsHeldforsaleMemberahg:HexinECommerceCompanyLimitedMember2021-07-142021-07-1400017023182021-07-132021-07-130001702318us-gaap:PrivatePlacementMember2021-08-092021-08-090001702318us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CreditConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:RestrictedStockUnitsRSUMember2021-04-012022-03-310001702318us-gaap:RestrictedStockUnitsRSUMember2018-04-012019-03-3100017023182021-04-012022-03-310001702318ahg:PhoenixIntelligentCreditGroupLtdMember2019-03-310001702318srt:MinimumMember2022-04-012022-09-300001702318srt:MaximumMember2022-04-012022-09-3000017023182021-09-300001702318ahg:PhoenixIntelligentCreditGroupLtdMember2019-01-080001702318ahg:MusketeerGroupInc.Member2018-08-090001702318ahg:PhoenixIntelligentCreditGroupLtdMember2022-09-300001702318ahg:MusketeerGroupInc.Member2022-09-300001702318ahg:PhoenixIntelligentCreditGroupLtdMember2022-03-310001702318ahg:MusketeerGroupInc.Member2022-03-3100017023182021-10-012022-03-310001702318ahg:SosInformationTechnologyNewYorkIncMember2022-07-272022-07-270001702318ahg:CommissionServicesMember2022-04-012022-09-300001702318ahg:CommissionServicesMember2021-04-012021-09-300001702318country:HK2022-09-300001702318ahg:OnlineMarketPlaceSegmentMember2021-04-012021-09-3000017023182020-05-310001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-09-3000017023182022-09-300001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-3100017023182022-03-3100017023182021-04-012021-09-30ahg:installmentahg:segmentiso4217:USDxbrli:purexbrli:sharesiso4217:USDxbrli:sharesiso4217:CNYiso4217:HKDahg:customerahg:loanahg:item
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF
1934
For the month of February 2023
Commission File Number: 001-38245
Akso Health Group
(Translation of registrant’s name into English)
Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo
Road
Chaoyang District, Beijing 100020
People’s Republic of China
Tel: +86 10 5370 9902
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(1): ☐
Note: Regulation S-T
Rule 101(b)(1) only permits the submission in paper of a
Form 6-K if submitted solely to provide an attached annual
report to security holders.
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): ☐
Note: Regulation S-T
Rule 101(b)(7) only permits the submission in paper of a
Form 6-K if submitted to furnish a report or other document
that the registrant foreign private issuer must furnish and make
public under the laws of the jurisdiction in which the registrant
is incorporated, domiciled or legally organized (the registrant’s
“home country”), or under the rules of the home country
exchange on which the registrant’s securities are traded, as long
as the report or other document is not a press release, is not
required to be and has not been distributed to the registrant’s
security holders, and, if discussing a material event, has already
been the subject of a Form 6-K submission or other Commission
filing on EDGAR.
Interim Financial Statements
Akso Health Group (formerly known as Xiaobai Maimai Inc.) is
furnishing this Form 6-K to provide six-month interim
financial statements and incorporate such financial statements into
the Company’s registration statements referenced below.
This Form 6-K is hereby incorporated by reference into the
registration statements of the Company (the “Company”) on Form S-8 (Registration
No. 333-223951) and on Form F-3s, as amended
(Registration Nos. No. 333-250020 and 333-252434), to the
extent not superseded by documents or reports subsequently filed or
furnished by the Company under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended.
Financial Statements and Exhibits.
Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
Dated:
|
February 16, 2023
|
Akso Health Group
|
|
|
|
|
|
|
By:
|
/s/ Yilin Wang
|
|
|
|
Name:
|
Yilin Wang
|
|
|
|
Title:
|
Chief Executive Officer
|
Xiaobia Maimai (NASDAQ:HX)
Historical Stock Chart
From May 2023 to Jun 2023
Xiaobia Maimai (NASDAQ:HX)
Historical Stock Chart
From Jun 2022 to Jun 2023
